1.        Abboud H, Probasco JC, Irani S, et al. Autoimmune encephalitis: proposed best practice recommendations for diagnosis and acute management. J Neurol Neurosurg Psychiatry. Jul 2021;92(7):757-768. doi:10.1136/jnnp-2020-325300

2.        Arino H, Munoz-Lopetegi A, Martinez-Hernandez E, et al. Sleep disorders in anti-NMDAR encephalitis. Neurology. Aug 11 2020;95(6):e671-e684. doi:10.1212/WNL.0000000000009987

3.        Armangue T, Titulaer MJ, Malaga I, et al. Pediatric anti-N-methyl-D-aspartate receptor encephalitis-clinical analysis and novel findings in a series of 20 patients. J Pediatr. Apr 2013;162(4):850-856 e2. doi:10.1016/j.jpeds.2012.10.011

4.        Cyril AC, Nair SS, Mathai A, Kannoth S, Thomas SV. Autoimmune encephalitis: Clinical diagnosis versus antibody confirmation. Ann Indian Acad Neurol. Oct-Dec 2015;18(4):408-11. doi:10.4103/0972-2327.165454

5.        Dalmau J, Geis C, Graus F. Autoantibodies to Synaptic Receptors and Neuronal Cell Surface Proteins in Autoimmune Diseases of the Central Nervous System. Physiol Rev. Apr 2017;97(2):839-887. doi:10.1152/physrev.00010.2016

6.        Dalmau J, Lancaster E, Martinez-Hernandez E, Rosenfeld MR, Balice-Gordon R. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol. Jan 2011;10(1):63-74. doi:10.1016/S1474-4422(10)70253-2

7.        de Bruijn M, Bruijstens AL, Bastiaansen AEM, et al. Pediatric autoimmune encephalitis: Recognition and diagnosis. Neurol Neuroimmunol Neuroinflamm. May 2020;7(3)doi:10.1212/NXI.0000000000000682

8.        Dubey D, Pittock SJ, Kelly CR, et al. Autoimmune encephalitis epidemiology and a comparison to infectious encephalitis. Ann Neurol. Jan 2018;83(1):166-177. doi:10.1002/ana.25131

9.        Graus F, Titulaer MJ, Balu R, et al. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol. Apr 2016;15(4):391-404. doi:10.1016/S1474-4422(15)00401-9

10.     Gresa-Arribas N, Titulaer MJ, Torrents A, et al. Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study. Lancet Neurol. Feb 2014;13(2):167-77. doi:10.1016/S1474-4422(13)70282-5

11.     Guasp M, Dalmau J. Autoimmune Encephalitis. Med Clin North Am. Mar 2025;109(2):443-461. doi:10.1016/j.mcna.2024.09.001

12.     Guasp M, Gine-Serven E, Maudes E, et al. Clinical, Neuroimmunologic, and CSF Investigations in First Episode Psychosis. Neurology. Jul 6 2021;97(1):e61-e75. doi:10.1212/WNL.0000000000012191

13.     Hah H, Lee Y, Lee HW, Jeon JY. Optic neuritis associated with seronegative autoimmune encephalitis: a case report. Encephalitis. Jul 2023;3(3):94-96. doi:10.47936/encephalitis.2023.00024

14.     Hebert J, Muccilli A, Wennberg RA, Tang-Wai DF. Autoimmune Encephalitis and Autoantibodies: A Review of Clinical Implications. J Appl Lab Med. Jan 5 2022;7(1):81-98. doi:10.1093/jalm/jfab102

15.     Hon KLE, Leung AK, Au CC, Torres AR. Autoimmune Encephalitis in Children: From Suspicion to Diagnosis. Cureus. Feb 12 2021;13(2):e13307. doi:10.7759/cureus.13307

16.     Huong NHT, Toan ND, Thien TB, et al. In Children, N-Methyl-D-Aspartate Receptor Antibody Encephalitis Incidence Exceeds That of Japanese Encephalitis in Vietnam. Open Forum Infect Dis. Dec 2024;11(12):ofae710. doi:10.1093/ofid/ofae710

17.     Kanniah G, Kumar R, Subramaniam G. Anti-NMDA Receptor Encephalitis: A Challenge in Psychiatric Settings. J Psychiatr Pract. Jan 6 2022;28(1):78-83. doi:10.1097/PRA.0000000000000602

18.     Kayser MS, Titulaer MJ, Gresa-Arribas N, Dalmau J. Frequency and characteristics of isolated psychiatric episodes in anti-N-methyl-d-aspartate receptor encephalitis. JAMA Neurol. Sep 1 2013;70(9):1133-9. doi:10.1001/jamaneurol.2013.3216

19.     Lancaster E, Lai M, Peng X, et al. Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen. Lancet Neurol. Jan 2010;9(1):67-76. doi:10.1016/S1474-4422(09)70324-2

20.     Lee ST, Lee HS, Lee WJ, et al. The safety and efficacy of intravenous immunoglobulin in autoimmune encephalitis. Ann Clin Transl Neurol. May 2022;9(5):610-621. doi:10.1002/acn3.51540

21.     Leypoldt F, Armangue T, Dalmau J. Autoimmune encephalopathies. Ann N Y Acad Sci. Mar 2015;1338(1):94-114. doi:10.1111/nyas.12553

22.     Li P, Yang T, Gu Y, Zhou J, Wang Z. Autoimmune encephalitis with coexisting antibodies to GABABR, GAD65, SOX1 and Ma2. BMC Neurol. Nov 13 2024;24(1):441. doi:10.1186/s12883-024-03938-z

23.     Liu CH, Chiu LC, Lee CC, Chan TM. Case Report: High-dose steroid and IVIG successful treatment in a case of COVID-19-associated autoimmune encephalitis: a literature review. Front Immunol. 2023;14:1240089. doi:10.3389/fimmu.2023.1240089

24.     Muniz-Castrillo S, Honnorat J. Genetic predisposition to autoimmune encephalitis and paraneoplastic neurological syndromes. Curr Opin Neurol. Jun 1 2024;37(3):329-337. doi:10.1097/WCO.0000000000001263

25.     Pruss H. Autoantibodies in neurological disease. Nat Rev Immunol. Dec 2021;21(12):798-813. doi:10.1038/s41577-021-00543-w

26.     Qu XP, Vidaurre J, Peng XL, Jiang L, Zhong M, Hu Y. Seizure Characteristics, Outcome, and Risk of Epilepsy in Pediatric Anti-N-Methyl-d-Aspartate Receptor Encephalitis. Pediatr Neurol. Apr 2020;105:35-40. doi:10.1016/j.pediatrneurol.2019.11.011

27.     Ryding M, Mikkelsen AW, Nissen MS, Nilsson AC, Blaabjerg M. Pathophysiological Effects of Autoantibodies in Autoimmune Encephalitides. Cells. Dec 20 2023;13(1)doi:10.3390/cells13010015

28.     Sequeira C, Lopes P. Antibody Negative Autoimmune Encephalitis: A Case Report. Acta Med Port. May 2 2021;34(5):378-382. doi:10.20344/amp.13793

29.     Shekunov J, Blacker CJ, Vande Voort JL, Tillema JM, Croarkin PE, Romanowicz M. Immune mediated pediatric encephalitis - need for comprehensive evaluation and consensus guidelines. BMC Neurol. Feb 3 2020;20(1):44. doi:10.1186/s12883-020-1605-y

30.     Solomon T, Michael BD, Smith PE, et al. Management of suspected viral encephalitis in adults--Association of British Neurologists and British Infection Association National Guidelines. J Infect. Apr 2012;64(4):347-73. doi:10.1016/j.jinf.2011.11.014

31.     Tan TH, Perucca P, O'Brien TJ, Kwan P, Monif M. Inflammation, ictogenesis, and epileptogenesis: An exploration through human disease. Epilepsia. Feb 2021;62(2):303-324. doi:10.1111/epi.16788

32.     Titulaer MJ, McCracken L, Gabilondo I, et al. Late-onset anti-NMDA receptor encephalitis. Neurology. Sep 17 2013;81(12):1058-63. doi:10.1212/WNL.0b013e3182a4a49c

33.     Titulaer MJ, McCracken L, Gabilondo I, et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol. Feb 2013;12(2):157-65. doi:10.1016/S1474-4422(12)70310-1

34.     Vasconcelos GA, Barreira RM, Antoniollo K, et al. Autoimmune Encephalitis in Latin America: A Critical Review. Front Neurol. 2020;11:606350. doi:10.3389/fneur.2020.606350

35.     Venkatesan A, Michael BD, Probasco JC, Geocadin RG, Solomon T. Acute encephalitis in immunocompetent adults. Lancet. Feb 16 2019;393(10172):702-716. doi:10.1016/S0140-6736(18)32526-1

36.     Wang C. A 22-year-old woman with nmda receptor antibody encephalitis possibly triggered by sars-cov-2 infection. Svoa Neurology. 2024;5(1):61-63. doi:10.58624/svoane.2024.05.0128

37.     Wright S, Hacohen Y, Jacobson L, et al. N-methyl-D-aspartate receptor antibody-mediated neurological disease: results of a UK-based surveillance study in children. Arch Dis Child. Jun 2015;100(6):521-6. doi:10.1136/archdischild-2014-306795